Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Velacur

K-Number: K233977 · 2024-09-04

ApplicantSonic Incytes
Decision Date2024-09-04
Product CodeIYO
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Velacur is a medical device manufactured by Sonic Incytes. It received FDA 510(k) clearance on 2024-09-04 under approval number K233977. The device is classified under product code IYO. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Velacur?

Velacur is a medical device that received FDA 510(k) clearance on 2024-09-04. It is manufactured by Sonic Incytes. The 510(k) number is K233977.

When was Velacur approved by the FDA?

Velacur received FDA 510(k) clearance on 2024-09-04, under approval number K233977.

What company makes Velacur?

Velacur is manufactured by Sonic Incytes.

What is the FDA product code for Velacur?

The FDA product code for Velacur is IYO.

Other Devices by Sonic Incytes

Related Devices (Code: IYO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.